Jim Cramer Calls Nvidia, Eli Lilly Partnership 'Monumental Effort' To 'Speed Up' Critical Drug Creation - NVIDIA (NASDAQ:NVDA)

Jim Cramer highlighted the underappreciated synergy between Nvidia Corp. (NASDAQ:NVDA) and Eli Lilly And Co. (NYSE:LLY), calling their deep collaboration a “monumental effort” to revolutionize drug development that Wall Street is foolishly dismissing as a “gigantic sideshow.”$1 Billion Validation Of AI In HealthcareWhile the broader market remains fixated on daily earnings fluctuations and inflation data, Cramer urged investors to focus on the structural shift happening in San Francisco.Nvidia and Eli Lilly ...